Trademark: 87070940
Status Date
Monday, January 27, 2020
Filing Date
Tuesday, June 14, 2016
Published for Opposition
Tuesday, November 1, 2016
Abandoned Date
Monday, January 27, 2020
5 Human pharmaceuticals for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases
Jan 27, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 27, 2020
Abandonment - No Use Statement Filed
May 30, 2019
Notice Of Approval Of Extension Request E-Mailed
May 29, 2019
Extension 5 Granted
May 22, 2019
Extension 5 Filed
May 29, 2019
Case Assigned To Intent To Use Paralegal
May 22, 2019
Teas Extension Received
Dec 21, 2018
Notice Of Approval Of Extension Request E-Mailed
Dec 19, 2018
Extension 4 Granted
Dec 19, 2018
Extension 4 Filed
Dec 19, 2018
Teas Extension Received
May 15, 2018
Notice Of Approval Of Extension Request E-Mailed
May 11, 2018
Extension 3 Granted
May 11, 2018
Extension 3 Filed
May 11, 2018
Teas Extension Received
Dec 2, 2017
Notice Of Approval Of Extension Request E-Mailed
Nov 30, 2017
Extension 2 Granted
Nov 30, 2017
Extension 2 Filed
Nov 30, 2017
Teas Extension Received
Jun 17, 2017
Notice Of Approval Of Extension Request E-Mailed
Jun 15, 2017
Extension 1 Granted
Jun 15, 2017
Extension 1 Filed
Jun 15, 2017
Teas Extension Received
Jun 15, 2017
Teas Change Of Correspondence Received
Dec 27, 2016
Noa E-Mailed - Sou Required From Applicant
Nov 1, 2016
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2016
Published For Opposition
Oct 12, 2016
Notification Of Notice Of Publication E-Mailed
Sep 21, 2016
Approved For Pub - Principal Register
Sep 20, 2016
Assigned To Examiner
Jun 21, 2016
New Application Office Supplied Data Entered In Tram
Jun 17, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
